Editor | Curator


Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani, and MAPS founder and psychedelic sector pioneer, Rick...

1000 Days Without Alcohol: Here’s What Happened

No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner party last night, we leisurely enjoyed three drinks...

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it used to raise $5.4 million.

Non-Hallucinogenic Psychedelics or Short Term vs Long Term Acting Psychedelics, Which are Best.

Great Interview with Adam Tubero, Jake Slomowitz and Steve McCraken, Analyst's who Drink the Kool Aide for the Best Perspectives and Opinions.

Journey Medical’s Growing Army of 1,000 Ketamine Therapists, are Available 24-7. Pure Genius. Interview With Jonathan Sabbagh, CEO

Journey Clinical is on a mission to expand access to transformative, evidence-based psychedelic therapies, starting with Ketamine-Assisted Psychotherapy (KAP). "I used psychedelics to treat my PTSD...

Guide to Miami Hedge Fund Week 2024

Each year, an intense series of alternative investment conferences take place in and around Miami. Here are the events for 2024 (and some notable changes). By Ed...

Helping Ketamine Clinics Succeed. Beyond Marketing.

Beyond Marketing Helps Transform Mental Health, TMS & Ketamine Practices into Thriving Businesses. The way patients behave and think is rapidly changing. Treatment centers, clinics...

Lykos Therapeutics (formerly MAPS) Raises $100 Million. Cha-Ching.

MDMA therapy company Lykos raises $100M in Series A funding as it eyes FDA approval (MarketWatch). MAPS Public Benefit Corp. changes name to Lykos Therapeutics. INVESTORS...

Editor | Curator